{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:54:05Z","timestamp":1789016045231,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1093\/annonc\/mdf253","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T14:40:11Z","timestamp":1033396811000},"page":"1264-1274","source":"Crossref","is-referenced-by-count":267,"title":["An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study"],"prefix":"10.1016","volume":"13","author":[{"given":"G.M.","family":"Mead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Sydes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Walewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Norbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guarnaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"McKendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Stenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf253_bb0010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopietic and lymphoid tissues","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0020","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V93.2.758","article-title":"What is Burkitt\u2019s lymphoma and when is it endemic?","volume":"93","author":"Wright","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0025","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"The Non-Hodgkin\u2019s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1008304329943","article-title":"Mature B-cell lymphoma\/leukemia in children and adolescents: intergroup pathologist consensus with the revised European\u2013American lymphoma classification","volume":"11","author":"Lones","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0035","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small non-cleaved, non-Burkitt\u2019s (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdf253_bb0040","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/annonc\/11.suppl_1.S35","article-title":"Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons","volume":"11","author":"Hutchison","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0045","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1182\/blood.V97.12.3713","article-title":"The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features","volume":"97","author":"Braziel","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0050","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphoma","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf253_bb0055","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt\u2019s lymphoma and B-cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1093\/annonc\/mdf253_bb0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","article-title":"Improved survival rate in children with stage III and IV B-cell non-Hodgkin\u2019s lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society","author":"Patte","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0065","first-page":"11","article-title":"High-dose methotrexate and continuous infusion Ara-C in childhood NHL","volume":"3","author":"Patte","year":"1986","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/JCO.1991.9.1.133","article-title":"HiC-Com: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt\u2019s Lymphoma and B-cell acute lymphoblastic leukemia","volume":"9","author":"Schwenn","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0080","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V80.10.2471.2471","article-title":"Favourable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of the three consecutive studies of the Berlin\u2013Frankfurt\u2013M\u00fcnster Group","volume":"80","author":"Reiter","year":"1992","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0085","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","article-title":"Non-Hodgkin\u2019s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage\u2014a report of the Berlin\u2013Frankfurt\u2013M\u00fcnster Group","volume":"13","author":"Reiter","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0959-8049(05)80348-X","article-title":"Curability of advanced Burkitt\u2019s lymphoma in children by intensive short-term chemotherapy","volume":"29A","author":"Gasparini","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf253_bb0095","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1054\/bjoc.1999.1083","article-title":"on behalf of the UKCCSG. Improved outcome in children with advanced stage B-cell non-Hodgkin\u2019s lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol","volume":"82","author":"Atra","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf253_bb0100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","article-title":"Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitts and non-Burkitt\u2019s types)","volume":"4","author":"Bernstein","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/JCO.1990.8.4.615","article-title":"Small non-cleaved cell lymphoma in adults: superior results for stages I\u2013III disease","volume":"8","author":"Lopez","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0002-9343(91)90573-G","article-title":"Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt\u2019s type) in American adults: results with treatment designed for acute lymphoblastic leukemia","volume":"90","author":"Straus","year":"1991","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/mdf253_bb0115","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/0959-8049(92)90235-T","article-title":"Treatment of poor prognosis Burkitt\u2019s lymphoma in adults with the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2018Oncologie P\u00e9diatrique LMB protocol: a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC)","volume":"28A","author":"Philip","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdf253_bb0120","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1994.12.10.2153","article-title":"Diffuse small non-cleaved-cell, non-Burkitt\u2019s lymphoma in adults: a high grade lymphoma responsive to ProMACE-based combination chemotherapy","volume":"12","author":"Longo","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0125","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","article-title":"Small non-cleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols","volume":"85","author":"Soussain","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","article-title":"Improved outcome in adult B-cell acute lymphoblastic leukemia","volume":"87","author":"Hoelzer","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf253_bb0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"Shipp","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf253_bb0145","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","article-title":"Molecular biology of Burkitt\u2019s lymphoma","volume":"18","author":"Hecht","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0150","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1200\/JCO.2000.18.16.3018","article-title":"CNS involvement in children with newly diagnosed non-Hodgkin\u2019s lymphoma","volume":"18","author":"Sandlund","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0155","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2000.18.10.2017","article-title":"Outcome of CNS disease at diagnosis in disseminated small noncleaved-cell lymphoma and B-cell leukemia: a Children\u2019s Cancer Group Study","volume":"18","author":"Gururangan","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0160","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","article-title":"Hyper-CVAD program in Burkitt\u2019s type adult acute lymphoblastic leukemia","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1200\/JCO.1990.8.5.809","article-title":"Allogenic bone marrow transplantation in adults with Burkitt\u2019s lymphoma or acute lymphoblastic leukemia in first complete remission","volume":"8","author":"Troussard","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf253_bb0170","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1200\/JCO.1996.14.9.2465","volume":"14","author":"Sweetenham","year":"1996","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419638445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419638445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/8\/1264\/334445\/mdf253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:35:42Z","timestamp":1582166142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419638445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0923753419638445"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf253","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}